Neurizon Therapeutics Explores Promising ALS Treatment
Pharmaust Limited (AU:NUZ) has released an update. Neurizon Therapeutics Limited has reported promising preclinical results for its lead drug ...
Neurizon Therapeutics Announces Promising ALS Drug Results
Pharmaust Limited (AU:NUZ) has released an update. Neurizon Therapeutics has announced promising preclinical results for its lead drug ...
HotCopper.com on MSN2h
ASX Market Update: Utilities and Banks lead bourse higher | November 15, 2024
The ASX200 has been up 0.35% at 8,255 points in afternoon trade. All four big banks are higher today and Westpac and ANZ are ...
Hosted on MSN1d
Neurizon sets out to capture the market in neurodegenerative disease therapies
This is the goal which Neurizon Therapeutics Ltd – the company formerly known as PharmAust – is pursuing through development ...
Neurizon Therapeutics Receives Positive Opinion on Orphan Medicinal Product Designation for NUZ-001 in Europe
Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing ...
manilatimes4d
ZTE unveils industry's first AI FWA Solution under its upgraded product philosophy GIS 2.0
ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology solutions, has debuted the industry's first AI-powered full-stack FWA solution, ...
stockhead9d
October Health Winners: Uscom, Respiri lead sluggish sector, but ‘time in the market, not timing, is key’
ASX healthcare stocks underperform, but optimism grows as Uscom, Respiri, Hitiq report mixed results and Artrya, Nyrada make ...
The Australian9d
Spark Plus sees 225pc upside in biotech player Neurizon
Spark Plus, an Asia-Pacific corporate advisory firm, puts a target price of 69.6 cents on Neurizon – a 225% upside to its ...
The Daily Telegraph13d
Neurizon’s strong September quarter to propel treatments for neurodegenerative diseases forward
The September 2024 quarter saw Neurizon Therapeutics receive positive interim results from the use of NUZ-001 to treat Amyotrophic Lateral Sclerosis. During this period, it advanced clinical-stage ...